-
Je něco špatně v tomto záznamu ?
Gastrointestinal comorbidities in patients with psoriasis in the Czech Republic: The results of 189 patients with psoriasis and 378 controls
K. Juzlova, J. Votrubova, M. Dzambova, D. Gopfertova, J. Hercogova, Z. Smerhovsky
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT13275
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
26498213
DOI
10.5507/bp.2015.048
Knihovny.cz E-zdroje
- MeSH
- C-reaktivní protein metabolismus MeSH
- časná diagnóza MeSH
- celiakie komplikace diagnóza epidemiologie MeSH
- chronická nemoc MeSH
- Crohnova nemoc komplikace diagnóza epidemiologie MeSH
- imunoglobulin A metabolismus MeSH
- kvalita života MeSH
- lidé MeSH
- počet leukocytů MeSH
- protilátky proti cytoplazmě neutrofilů metabolismus MeSH
- psoriáza komplikace epidemiologie MeSH
- studie případů a kontrol MeSH
- transglutaminasy metabolismus MeSH
- ulcerózní kolitida komplikace diagnóza epidemiologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
AIMS: TheAIM of the study was to investigate gastrointestinal comorbidities, identify risk factors and detect the early stages of autoimmune gastrointestinal diseases, such as Crohn's disease, ulcerative colitis and coeliac disease in patients with psoriasis. METHODS: This was a hospital-based case-control study. Patients with chronic plaque psoriasis were included as cases. The control group consisted of patients with other skin diseases and who complied with the same selection criteria as cases. Two controls were selected per one case. We analysed the following antibodies (ASCA, AEP, p-ANCA, AGC, EMA, ARA, tTG, AGA) and non-specific signs of gastrointestinal diseases. RESULTS: There were significant differences between cases and controls in several parameters. Leucocyte count, CRP, total protein, transglutaminase IgA antibodies and p-ANCA were statistically significant between groups (P < 0.05). In the binary logistic model, leucocyte count and p-ANCA (for all parameters included in the logistic model P ≤ 0.001) were associated with psoriasis. CONCLUSION: Patients with psoriasis should be regularly screened for coeliac and inflammatory bowel disease. Early diagnosis of gastrointestinal diseases and risk factors may prevent complications and greatly improve the patient's quality of life.
Department of Dermatovenereology 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Epidemiology 2nd Faculty of Medicine Charles University Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17006143
- 003
- CZ-PrNML
- 005
- 20200714123725.0
- 007
- ta
- 008
- 170210s2016 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2015.048 $2 doi
- 035 __
- $a (PubMed)26498213
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Jůzlová, Kateřina $u Department of Dermatovenereology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic; Department of Epidemiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic $d 1983- $7 xx0230484
- 245 10
- $a Gastrointestinal comorbidities in patients with psoriasis in the Czech Republic: The results of 189 patients with psoriasis and 378 controls / $c K. Juzlova, J. Votrubova, M. Dzambova, D. Gopfertova, J. Hercogova, Z. Smerhovsky
- 520 9_
- $a AIMS: TheAIM of the study was to investigate gastrointestinal comorbidities, identify risk factors and detect the early stages of autoimmune gastrointestinal diseases, such as Crohn's disease, ulcerative colitis and coeliac disease in patients with psoriasis. METHODS: This was a hospital-based case-control study. Patients with chronic plaque psoriasis were included as cases. The control group consisted of patients with other skin diseases and who complied with the same selection criteria as cases. Two controls were selected per one case. We analysed the following antibodies (ASCA, AEP, p-ANCA, AGC, EMA, ARA, tTG, AGA) and non-specific signs of gastrointestinal diseases. RESULTS: There were significant differences between cases and controls in several parameters. Leucocyte count, CRP, total protein, transglutaminase IgA antibodies and p-ANCA were statistically significant between groups (P < 0.05). In the binary logistic model, leucocyte count and p-ANCA (for all parameters included in the logistic model P ≤ 0.001) were associated with psoriasis. CONCLUSION: Patients with psoriasis should be regularly screened for coeliac and inflammatory bowel disease. Early diagnosis of gastrointestinal diseases and risk factors may prevent complications and greatly improve the patient's quality of life.
- 650 _2
- $a protilátky proti cytoplazmě neutrofilů $x metabolismus $7 D019268
- 650 _2
- $a C-reaktivní protein $x metabolismus $7 D002097
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a celiakie $x komplikace $x diagnóza $x epidemiologie $7 D002446
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a ulcerózní kolitida $x komplikace $x diagnóza $x epidemiologie $7 D003093
- 650 _2
- $a Crohnova nemoc $x komplikace $x diagnóza $x epidemiologie $7 D003424
- 650 _2
- $a Česká republika $x epidemiologie $7 D018153
- 650 _2
- $a časná diagnóza $7 D042241
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoglobulin A $x metabolismus $7 D007070
- 650 _2
- $a počet leukocytů $7 D007958
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a psoriáza $x komplikace $x epidemiologie $7 D011565
- 650 _2
- $a kvalita života $7 D011788
- 650 _2
- $a transglutaminasy $x metabolismus $7 D011503
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Votrubová, Jana $u Department of Dermatovenereology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic; Department of Epidemiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic $7 _AN071117
- 700 1_
- $a Krásová, Martina $u Department of Dermatovenereology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic; Department of Epidemiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic $7 xx0210575
- 700 1_
- $a Göpfertová, Dana, $d 1951- $u Department of Epidemiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic $7 jn99240000250
- 700 1_
- $a Třešňák Hercogová, Jana, $u Department of Dermatovenereology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic $d 1959- $7 nlk19990073221
- 700 1_
- $a Smerhovský, Zdeněk $u Department of Epidemiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic $7 _AN077445
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 1 (2016), s. 100-105
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20170210 $b ABA008
- 991 __
- $a 20200714123721 $b ABA008
- 999 __
- $a ok $b bmc $g 1192626 $s 966790
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 160 $c 1 $d 100-105 $e 20151021 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- GRA __
- $a NT13275 $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20170210